Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 2,450 $ 1,554
Marketable debt securities, available for sale 4,229 6,687
Escrow receivable 4,830 4,830
Accounts receivable, net 788 2,968
Inventory 1,611 1,903
Prepaid expenses and other current assets 218 296
Total current assets 14,126 18,238
Property, plant and equipment, net of accumulated depreciation of $5,955 and $5,854, respectively 2,446 2,499
TOTAL ASSETS 16,572 20,737
Current liabilities    
Accounts payable 258 437
Accrued advertising and other allowances 101 101
Dividend payable 2,929
Other current liabilities 511 766
Total current liabilities 870 4,233
COMMITMENTS AND CONTINGENCIES
Stockholders' equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued
Common stock authorized 50,000,000, $.0005 par value, issued 28,208,707 and 28,201,541 shares, respectively 14 14
Additional paid-in capital 59,667 59,471
Retained earnings 3,520 4,533
Treasury stock, at cost, 16,652,022 and 16,652,022 shares, respectively (47,490) (47,490)
Accumulated comprehensive loss (9) (24)
Total stockholders' equity 15,702 16,504
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 16,572 $ 20,737